Skip to content
Back to technologies
Digital Health Prototype testing

Gait Quality Diagnostics — Neurological Disorders

Wearable AI-powered sensors that assess gait quality and classify neurological disorders in real time.

Gait Quality Diagnostics — Neurological Disorders

Multiple sclerosis (MS) is the most common cause of neurological disability in young and middle-aged people. MS has a physical, psychological and financial impact on patients and their families. Up to 85 % of patients with MS identify gait disorders as a major problem. The ability to monitor the development of the disorder over time is highly valued diagnostic measure. Falling because of old age, neurological disorders, movement disorders and injuries can be predicted by the assessment of change in gait quality.

A set of wearable sensors and the first computing unit – assessing the overall gait quality in real time while walking, providing immediate feedback to the user or the physician. Subsequently, the second unit identifies several gait disorders, their extent and probable cause. In both cases, the evaluation is performed using machine learning modules. Both approaches show relatively great robustness of the approach used and the relative simplicity of computer performance, especially in the near future. For general use the first step processing can warn patients or elderly people on the probability of falling.

Easy to Use

Simple, easy to use, yet reliable and robust diagnostics.

Automatic Evaluation

Automatic evaluation – no expert needed for daily use of a patient but may work as a decision support for expert physician - neurologists.

Normal Activity Use

No laboratory assessment distortion, but real world – normal activity view.

One Sensor

No multiple joint sensors and expensive SW/HW needed ‑ just one sensor unit well positioned.

Worldwide increasing incidence of MS was estimated to be 2.8 million people in 2020, in developed countries is double to triple incidence ‑ it might be due to lack of qualified diagnostics available in the developing countries ‑ the numbers are therefore supposedly undervalued. Can be helpful for many other neurological or movement diseases and elderly in general. Technology is owned by University Hospital Hradec Králové . Czech patent application PV 2021-331 and PCT application PCT/CZ2022/050062 (priority 30. 06. 2022) was submitted. Prototype testing in progress .

Company/co‑development partner to bring technology to market as MD/Diagnostics and/or as a general public “indicative” device to warn about the risk of falling.

Seeking for development partner, commercial partner or licencing.

  1. Non-MD/Diag. device – wearable “fall prediction”

  2. Diagnostic – wearable – good/bad gait indicator

  3. Diagnostic – wearable + mobile/tablet - gait disorder type and severity analyser and classifier.

Team of Inventors

Assoc. prof. Oldřich Vyšata & team

University Hospital Hradec Králové

Neurological clinic, University Hospital Hradec Králové

Investigator & coinvestigator of multiple grants

Author & coauthor of more than 120 papers in prestigious international journals

prof. MUDr. Martin Vališ, Ph.D., FEAN

University Hospital Hradec Králové

Head of Clinic of Neurology (UH HK)

Head of Department of Neurology (MF CU HK)

Publications with IF: 240, WOS 4900

Committee Member of the Section of cognitive neurology and neuroimmunology (CNS-CzMA)

Committee Member of the Alzheimer’s Foundation–CR

Fellow of European Academy of Neurology

Principal investigator & coinvestigator of multiple research projects and clinical studies

HTML Website Maker